Highly Drug-resistant Focal Epilepsy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-01-31
Clinical Trial Update: An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy [Phase 2]
Open-label extension study of UCB0942 in adults with highly drug-resistant focal epilepsy has been terminated; results posted in 2022.